MedinCell S.A. (EPA:MEDCL)
France · Delayed Price · Currency is EUR 22.56
-0.52 (-2.25%)
At close: Jan 30, 2026
MedinCell Market Cap
MedinCell has a market cap or net worth of €746.8 million as of January 30, 2026. Its market cap has increased by 57.38% in one year.
Market Cap
746.80M
Enterprise Value
766.89M
Revenue
32.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
€22.56
Market Cap Chart
Since October 8, 2018, MedinCell's market cap has increased from 146.11M to 746.80M, an increase of 411.14%. That is a compound annual growth rate of 24.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 746.80M | -10.48% |
| Dec 31, 2025 | 834.19M | 71.72% |
| Dec 31, 2024 | 485.79M | 134.93% |
| Dec 29, 2023 | 206.78M | 33.30% |
| Dec 30, 2022 | 155.12M | -37.61% |
| Dec 31, 2021 | 248.65M | 10.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DBV Technologies | 1.12B |
| Inventiva | 955.16M |
| Nanobiotix | 844.85M |
| Valneva SE | 674.24M |
| Genfit | 278.85M |
| Transgene | 248.09M |
| Cellectis | 235.06M |
| Innate Pharma | 145.05M |